Skip to content

Clinical trials

Glomerulonephritis, IGA trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20121
20131
20151
20183
20191
20201
20213
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Calliditas Therapeutics AB4
Novartis Pharmaceuticals3
Uppsala University Hospital2
Alnylam Pharmaceuticals1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Amgen1
Omeros Corporation1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA14
Renal Insufficiency, Chronic3
Glomerulonephritis2
Proteinuria2
Glomerulosclerosis, Focal Segmental1
IgA Vasculitis1
Nephritis, Hereditary1
Nephrosis, Lipoid1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.